↓ Skip to main content

International prescribing practices in obsessive–compulsive disorder (OCD)

Overview of attention for article published in Human Psychopharmacology: Clinical & Experimental, June 2016
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
2 X users

Citations

dimensions_citation
23 Dimensions

Readers on

mendeley
68 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
International prescribing practices in obsessive–compulsive disorder (OCD)
Published in
Human Psychopharmacology: Clinical & Experimental, June 2016
DOI 10.1002/hup.2541
Pubmed ID
Authors

Vlasios Brakoulias, Vladan Starcevic, Amparo Belloch, Liliana Dell'Osso, Ygor A Ferrão, Leonardo F Fontenelle, Christine Lochner, Donatella Marazziti, Andrew Martin, Hisato Matsunaga, Euripedes C Miguel, Y C Janardhan Reddy, Maria C do Rosário, Roseli G Shavitt, Arumugham Shyam Sundar, Dan Joseph Stein, Kirupamani Viswasam

Abstract

To assess rates of psychotropic medication use in patients with obsessive-compulsive disorder (OCD) in seven different countries on five continents and to compare these with international treatment guidelines. Researchers in the field of OCD were invited to contribute summary statistics on the characteristics of their patients with OCD and on their incidence of psychotropic use. Consistency of summary statistics across countries was evaluated. The data came from Brazil (n = 955), Italy (n = 750), South Africa (n = 555), Japan (n = 382), Australia (n = 213), India (n = 202) and Spain (n = 82). The majority (77.9%; n = 2445) of the total sample of 3139 participants received a psychotropic medication. Consistent with international guidelines, selective serotonin reuptake inhibitors (SSRIs) were most commonly used (73.5%, n = 1796), but their use ranged from 59% in Australia to 96% in Japan. Clomipramine use varied from 5% in Japan and South Africa to 26% in India and Italy. Atypical antipsychotic use ranged from 12% in South Africa to 50% in Japan. Pharmacotherapy for OCD varied significantly across sites. Prospective studies are required to determine the cultural, pharmacoeconomic and pharmacogenomic factors that may play a role in the variation in prescribing practices internationally and whether these variations influence treatment outcomes. Copyright © 2016 John Wiley & Sons, Ltd.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 68 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
South Africa 1 1%
Unknown 67 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 11 16%
Student > Bachelor 10 15%
Researcher 9 13%
Professor 7 10%
Student > Doctoral Student 6 9%
Other 5 7%
Unknown 20 29%
Readers by discipline Count As %
Psychology 12 18%
Medicine and Dentistry 11 16%
Pharmacology, Toxicology and Pharmaceutical Science 5 7%
Nursing and Health Professions 4 6%
Neuroscience 4 6%
Other 9 13%
Unknown 23 34%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 December 2017.
All research outputs
#16,148,389
of 25,522,520 outputs
Outputs from Human Psychopharmacology: Clinical & Experimental
#583
of 837 outputs
Outputs of similar age
#206,008
of 356,045 outputs
Outputs of similar age from Human Psychopharmacology: Clinical & Experimental
#9
of 12 outputs
Altmetric has tracked 25,522,520 research outputs across all sources so far. This one is in the 34th percentile – i.e., 34% of other outputs scored the same or lower than it.
So far Altmetric has tracked 837 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.4. This one is in the 28th percentile – i.e., 28% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 356,045 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 39th percentile – i.e., 39% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 12 others from the same source and published within six weeks on either side of this one. This one is in the 16th percentile – i.e., 16% of its contemporaries scored the same or lower than it.